Clinical trial · Observational
Craniopharyngioma With Tumoral Hemorrhage
Clinical Features and Risk Factors of Craniopharyngioma With Tumoral Hemorrhage
NCT04937335CI-TRIAL-00052435completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Clinical data of 185 consecutive patients receiving resective operation with a pathological diagnosis of craniopharyngioma in our hospital between January 2013 and February 2021 were collected. Among these patients, 18 of them were recognized as craniopharyngioma with tumoral hemorrhage during the operation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Apoplexy | — | UNRESOLVED | — |
| Craniopharyngioma | Craniopharyngioma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| intratumoral hemorrhage | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Non-hemorrhage group
- description
- Patients recognized as craniopharyngioma pathologically without tumoral hemorrhage observed during the operation
- label
- Hemorrhage group
- description
- Patients recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation
- interventionNames
- Other: intratumoral hemorrhage
Primary outcomes (1)
- measure
- craniopharyngioma with tumoral hemorrhage
- timeFrame
- during the operation
- description
- Current study is a case-control study whose primary outcome is tumoral hemorrhage observed during the operation, which devided the craniopharyngioma patients into hemorrhage group and non-hemorrhage group.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * receive resective operation with a pathological diagnosis of craniopharyngioma in our hospital * enter our hospital between January 2013 and February 2021 Exclusion Criteria: * have a non-craniopharyngioma or unverified pathological diagnosis at discharge * have received surgical or radiological treatment on the sellar region * receive treatment of coagulation modulation, immunosuppressive agents or chemotherapeutic drugs * combine with other clinical emergencies including acute myocardial infarction, cerebral stroke, trauma and sepsis at admission * have been diagnosed with other tumors, hematological diseases, autoimmune diseases, liver failure or renal failure
References
Publications (0)
Data not yet available
No reference posted for this study.